Skip to content

Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical, sold RARE on Sep 15, 2026

Data as of Oct 16

▼ SELL$17.4K1,283 shares at $13.57Theodore Alan Huizenga SVP, Chief Accounting OfficerRARE Ultragenyx Pharmaceutical Inc.
Watch RARE
Traded
Sep 15, 2026
Disclosed
Sep 15, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Theodore Alan Huizenga, SVP, Chief Accounting Officer at Ultragenyx Pharmaceutical, sold RARE on Sep 15, 2026TRADEDDISCLOSED
RARESimilar stocks (XLV — its sector index fund), rebased to RARE's price on the disclosure day
RARE since disclosure
+11.2%
after the sale
Similar stocks (XLV) since disclosure
+5.4%
XLV — its sector index fund

Change in closing price from Sep 15, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on RARE →